TikoMed will be speaking at Europe CEO

nov, 14, tue

Time:


”Given this opportunity to speak at this first Europe CEO meeting by Boston Biotech Conferences, will be an excellent chance to place TikoMed and its projects on the map of some of the most important minds that shapes the future of Europe’s pharma and Biotech industry” / Adam Bruce, Founder and CEO

Europe CEO is a networking forum for CEOs and decision makers in the life sciences. Participants gain insights from off-the-record discussion panels, keynotes, and fireside chats featuring CEOs and thought leaders from several of the world’s leading biopharmaceutical companies. Healthcare investors and leading researchers also participate. 

Co-hosts and Speakers include: Adam BruceCEO & Founder, Tikomed; Luc DochezCEO, Tusk Therapeutics; Marc de GaridelChairman, IPSEN; Don DeBethizyChairman, Albumedix; John Haurum, CEO, F-Star Biotechnology; Adi Hoess, CEO, Affimed; Jan-Anders KarlssonCEO, Verona Pharma; Jonathan LewisCEO, Samus Therapeutics; Ivana Magovcevic-LiebischEVP, Axcella Health; Elias PapatheodorouCEO, Genkyotex; Joe WileyCEO, Amryt Pharma

EUROPE CEO – NOVEMBER 14, FOUR SEASONS LONDON

Co-hosts and Speakers include: Adam BruceCEO & Founder, Tikomed; Luc DochezCEO, Tusk Therapeutics; Marc de GaridelChairman, IPSEN; Don DeBethizyChairman, Albumedix; John Haurum, CEO, F-Star Biotechnology; Adi Hoess, CEO, Affimed; Jan-Anders KarlssonCEO, Verona Pharma; Ed Kayeformer CEO, Sarepta; Jonathan LewisCEO, Samus Therapeutics; Ivana Magovcevic-LiebischEVP, Axcella Health; Elias PapatheodorouCEO, Genkyotex; Joe WileyCEO, Amryt Pharma

TimeAgenda
7:00-8:00 amRegistration and Networking Breakfast
8:00-8:30 amWelcome and Opening Remarks
8:30-9:00 amAlternate Sources of Funding
9:00-10:00 amGlobal Perspectives on Funding: The VC Perspective
10:00-10:20 amModerated Keynote
10:20-10:50 amNetworking Break
10:50-11:20 amRegulatory Hurdles: Access Across Borders
11:20-11:50 amGaining Investment Overseas
11:50-12:20 pmPublic and Private Markets: Challenges and Opportunities across Borders
12:20-1:20 pmNetworking Lunch
1:20-1:50 pmThe Impact of ACA Reform and Brexit on Global Markets
1:50-2:20 pmBiotech Partnering: Strategies for Success
2:20-2:50 pmAcademia & Biotech Collaborations: Lessons Learned from Global Markets
2:50-3:20 pmNetworking Break
3:20-3:50 pmFireside Chat
3:50-4:20 pmTherapeutic Market Focus: Immuno-Oncology
4:20-4:50 pmLeveraging Emerging Markets
4:50-5:20 pmNavigating Market Access
5:20-6:00 pmCocktail Reception